CRYO-CELL INTERNATIONAL, INC. Notes Payable, Noncurrent
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Notes Payable, Noncurrent of $8.08 million as of 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermNotesPayable · last filed 2026-07-15
- 2026-05-31: Notes Payable, Noncurrent $8.08M.
- 2026-02-28: Notes Payable, Noncurrent $8.13M.
- 2025-11-30: Notes Payable, Noncurrent $8.17M.
- 2025-08-31: Notes Payable, Noncurrent $8.21M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2026-05-31 | $8.08M 10-Q · filed 2026-07-15 |
| 2026-02-28 | $8.13M 10-Q · filed 2026-04-14 |
| 2025-11-30 | $8.17M 10-Q · filed 2026-07-15 |
| 2025-08-31 | $8.21M 10-Q · filed 2025-10-15 |
| 2025-05-31 | $8.24M 10-Q · filed 2025-07-15 |
| 2025-02-28 | $8.27M 10-Q · filed 2025-04-14 |
| 2024-11-30 | $8.31M 10-K · filed 2026-02-27 |
| 2024-08-31 | $8.33M 10-Q · filed 2024-10-15 |
| 2024-05-31 | $8.36M 10-Q · filed 2024-07-15 |
| 2024-02-29 | $8.39M 10-Q · filed 2024-04-15 |
| 2023-11-30 | $8.43M 10-K · filed 2025-02-28 |
| 2023-08-31 | $8.47M 10-Q · filed 2023-10-12 |
| 2023-05-31 | $8.51M 10-Q · filed 2023-07-14 |
| 2023-02-28 | $8.55M 10-Q · filed 2023-04-21 |
| 2022-11-30 | $8.58M 10-K · filed 2024-02-28 |
| 2022-08-31 | $8.61M 10-Q · filed 2022-10-18 |
| 2021-11-30 | $0.00 10-K · filed 2023-02-28 |
| 2021-05-31 | $326.29K 10-Q · filed 2021-07-15 |
| 2021-02-28 | $1.09M 10-Q · filed 2021-04-14 |
| 2020-11-30 | $2.84M 10-K · filed 2022-02-22 |
| 2020-08-31 | $3.60M 10-Q · filed 2020-10-15 |
| 2020-05-31 | $4.35M 10-Q · filed 2020-07-10 |
| 2020-02-29 | $5.11M 10-Q · filed 2020-04-14 |
| 2019-11-30 | $5.86M 10-K · filed 2021-03-01 |
| 2019-08-31 | $6.60M 10-Q · filed 2019-10-15 |
| 2019-05-31 | $8.35M 10-Q · filed 2019-07-15 |
| 2019-02-28 | $9.10M 10-Q · filed 2019-04-15 |
| 2018-11-30 | $9.84M 10-K · filed 2020-02-28 |
| 2018-08-31 | $11.59M 10-Q · filed 2018-10-15 |
| 2018-05-31 | $4.35M 10-Q · filed 2018-07-16 |
| 2018-02-28 | $4.82M 10-Q · filed 2018-04-16 |
| 2017-11-30 | $5.30M 10-K · filed 2019-02-28 |
| 2017-08-31 | $5.77M 10-Q · filed 2017-10-16 |
| 2017-05-31 | $6.89M 10-Q · filed 2017-07-07 |
| 2017-02-28 | $7.35M 10-Q · filed 2017-04-13 |
| 2016-11-30 | $7.82M 10-K · filed 2018-02-28 |
| 2016-08-31 | $8.65M 10-Q · filed 2016-10-17 |
| 2016-05-31 | $650.10K 10-Q · filed 2016-07-11 |
| 2016-02-29 | $790.96K 10-Q · filed 2016-04-14 |
| 2015-11-30 | $868.95K 10-K · filed 2017-02-28 |
| 2015-08-31 | $947.25K 10-Q · filed 2015-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |